These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8785938)

  • 1. The reduction of the use of challenge testing to provide evidence of efficacy in tests of immunological veterinary medicinal products (IVMPs).
    Webster CJ
    Dev Biol Stand; 1996; 86():103-9. PubMed ID: 8785938
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 3. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of challenge procedures in the evaluation of poultry vaccines.
    Jungbäck C; Finkler H
    Dev Biol Stand; 1996; 86():157-63. PubMed ID: 8785945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S
    ALTEX; 2010; 27(1):1. PubMed ID: 20397314
    [No Abstract]   [Full Text] [Related]  

  • 7. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of the product equivalence of monoclonal antibodies for therapeutic and in vivo diagnostic human use in case of change from ascitic to in vitro production.
    Schäffner G; Haase M; Giess S
    Dev Biol Stand; 1996; 86():319-20. PubMed ID: 8785963
    [No Abstract]   [Full Text] [Related]  

  • 9. Reducing the use of the target animal batch safety test for veterinary vaccines.
    Roberts B; Lucken RN
    Dev Biol Stand; 1996; 86():97-102. PubMed ID: 8785997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three Rs of Russell & Burch and the testing of biological products.
    Balls M; Straughan DW
    Dev Biol Stand; 1996; 86():11-8. PubMed ID: 8785939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternatives to in vivo potency and protection tests for veterinary vaccines.
    Lucken RN
    Dev Biol Stand; 1999; 101():67-72. PubMed ID: 10566777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency as an alternative to potency testing.
    Duchow K
    Dev Biol (Basel); 2012; 134():119-22. PubMed ID: 22888604
    [No Abstract]   [Full Text] [Related]  

  • 14. Opportunities to reduce the use of animals in the potency and toxicity testing of toxoid vaccines.
    Knight PA
    Dev Biol Stand; 1996; 86():185-97. PubMed ID: 8785948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaLISA assays to improve the vaccine development process.
    Cosentino G
    Dev Biol (Basel); 2012; 134():107-11. PubMed ID: 22888602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia.
    Castle P
    Dev Biol Stand; 1996; 86():21-9. PubMed ID: 8785951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poultry vaccines: an analysis of the animal trials required for vaccine testing and the way to reduce or refine these tests.
    Jungbäck C; Küchler B; Schirk EM
    Dev Biol Stand; 1999; 101():79-83. PubMed ID: 10566779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.